JP Morgan Chase
GNCA

JP Morgan Chase’s Genocea Biosciences, Inc. GNCA Stock Holding History

JP Morgan Chase’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10
Closed – – 6040
2020
Q2 		$0 Buy
+10
New +$23 ﹤0.01% 5955
2018
Q2 		– Sell
-6,100
Closed -$51K – 5806
2018
Q1 		$51K Buy
6,100
+5,334
+696% +$44.3K ﹤0.01% 4808
2017
Q4 		$7K Buy
+766
New +$7.7K ﹤0.01% 5298
2017
Q2 		– Sell
-4,464
Closed -$217K – 5389
2017
Q1 		$217K Buy
+4,464
New +$174K ﹤0.01% 4040
2016
Q2 		– Sell
-15,888
Closed -$983K – 5094
2016
Q1 		$983K Sell
15,888
-1,200
-7% -$38.1K ﹤0.01% 3077
2015
Q4 		$720K Buy
+17,088
New +$814K ﹤0.01% 3257
2014
Q4 		– Sell
-1,718
Closed -$124K – 4441
2014
Q3 		$124K Buy
+1,718
New +$188K ﹤0.01% 4068

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's GNCA Position: Q3 2020 in Review

JP Morgan Chase sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2020, closing a stake of 10 shares.

JP Morgan Chase first reported a position in GNCA in Q3 2014 and held it in 7 quarters. The position peaked at $983K in Q1 2016. 39 funds tracked by Wall St. Rank hold GNCA as of Q3 2020.

  • JP Morgan Chase reported no remaining Genocea Biosciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • JP Morgan Chase sold 10 Genocea Biosciences, Inc. shares in Q3 2020.
  • JP Morgan Chase first reported a position in Genocea Biosciences, Inc. in Q3 2014 and held it in 7 quarters.
  • JP Morgan Chase's Genocea Biosciences, Inc. position peaked at $983K in Q1 2016.
  • 39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2020.

Based on JP Morgan Chase's 13F filing for Q3 2020, filed 12 Nov 2020.